Published June 30, 2024
| Version v1
Dataset
Open
Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses (RawData)
Creators
- 1. Victoria University
- 2. Institute for Sustainable Industries and Liveable Cities, Victoria University, Melbourne 8001, VIC, Australia
- 3. AquaMem Consultants, Rodeo, NM 88056, USA
- 4. Pepmetics Inc., 772 Murphy Place, Victoria, BC V6Y 3H4, Canada
- 5. Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada
- 6. Institute for Health and Sport, Victoria University, Melbourne 3030, VIC, Australia
- 7. 4th Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece
- 8. NewDrug PC, Patras Science Park, Patras 26504, Greece
- 9. Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece
- 10. Department of Chemistry, University of Patras, 26504 Patras, Greece
Files
Raw_Data_PanAntiviral.zip
Files
(286.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:6083ffdb8d99d243a2eec8d9816dfd33
|
286.7 MB | Preview Download |